These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29983335)

  • 41. Gene therapy for inherited retinal degenerations.
    Dalkara D; Sahel JA
    C R Biol; 2014 Mar; 337(3):185-92. PubMed ID: 24702845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neonatal systemic delivery of scAAV9 in rodents and large animals results in gene transfer to RPE cells in the retina.
    Joussemet B; Belbellaa B; Mendes-Madeira A; Bucher T; Briot-Nivard D; Dubreil L; Colle MA; Cherel Y; Moullier P; Rolling F
    Exp Eye Res; 2011 Oct; 93(4):491-502. PubMed ID: 21723863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
    Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
    Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
    Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
    Gene Ther; 2007 Feb; 14(4):292-303. PubMed ID: 17024105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospects for gene therapy of inherited retinal disease.
    Bainbridge JW
    Eye (Lond); 2009 Oct; 23(10):1898-903. PubMed ID: 19151647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent Advancements in Gene Therapy for Hereditary Retinal Dystrophies.
    Öner A
    Turk J Ophthalmol; 2017 Dec; 47(6):338-343. PubMed ID: 29326851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene therapy for achromatopsia.
    Michalakis S; Schön C; Becirovic E; Biel M
    J Gene Med; 2017 Mar; 19(3):. PubMed ID: 28095637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye.
    Rodrigues GA; Shalaev E; Karami TK; Cunningham J; Slater NKH; Rivers HM
    Pharm Res; 2018 Dec; 36(2):29. PubMed ID: 30591984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8.
    Natkunarajah M; Trittibach P; McIntosh J; Duran Y; Barker SE; Smith AJ; Nathwani AC; Ali RR
    Gene Ther; 2008 Mar; 15(6):463-7. PubMed ID: 18004402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minicircle Delivery to the Neural Retina as a Gene Therapy Approach.
    Staurenghi F; McClements ME; Salman A; MacLaren RE
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The road toward human gene therapy--a 25-year perspective.
    Friedmann T
    Ann Med; 1997 Dec; 29(6):575-7. PubMed ID: 9562527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Top Five Gene Therapy Stories of 2019.
    Flotte TR
    Hum Gene Ther; 2019 Jan; 30(1):1-2. PubMed ID: 30628861
    [No Abstract]   [Full Text] [Related]  

  • 53. Breaking the Barriers of Genetic and Metabolic Disorders.
    Büning H; Bosch F; Mingozzi F
    Hum Gene Ther; 2019 Oct; 30(10):1177-1179. PubMed ID: 31573872
    [No Abstract]   [Full Text] [Related]  

  • 54. Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward.
    Bennett J
    Mol Ther; 2017 May; 25(5):1076-1094. PubMed ID: 28391961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Blunt End: Surgical Challenges of Gene Therapy for Inherited Retinal Diseases.
    Davis JL
    Am J Ophthalmol; 2018 Dec; 196():xxv-xxix. PubMed ID: 30194931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene delivery to the retina: from mouse to man.
    Bennett J; Chung DC; Maguire A
    Methods Enzymol; 2012; 507():255-74. PubMed ID: 22365778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Birth of a new therapeutic platform: 47 years of adeno-associated virus biology from virus discovery to licensed gene therapy.
    Flotte TR
    Mol Ther; 2013 Nov; 21(11):1976-81. PubMed ID: 24201212
    [No Abstract]   [Full Text] [Related]  

  • 58. Three Decades of Clinical Gene Therapy: From Experimental Technologies to Viable Treatments.
    Tremblay JP; Annoni A; Suzuki M
    Mol Ther; 2021 Feb; 29(2):411-412. PubMed ID: 33472032
    [No Abstract]   [Full Text] [Related]  

  • 59. Recent advances in liver-directed gene therapy for dyslipidemia.
    Oka K; Chan L
    Curr Atheroscler Rep; 2002 May; 4(3):199-207. PubMed ID: 11931717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Laser-assisted targeted gene delivery to degenerated retina improves retinal function.
    Batabyal S; Kim S; Wright W; Mohanty S
    J Biophotonics; 2021 Jan; 14(1):e202000234. PubMed ID: 33026157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.